The antiarrhythmic agent cibenzoline inhibits K(ATP) channels by binding to Kir6.2

Biochemical and Biophysical Research Communications

Volumn 251, Issue 2, 1998, Pages 477-481

  Mukai, Eri ^a   Ishida, Hitoshi ^a,b   Horie, Minoru ^a   Noma, Akinori ^a   Seino, Yutaka ^a   Takano, Makoto ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIARRHYTHMIC AGENT; CIBENZOLINE; GLIBENCLAMIDE; MUTANT PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN INHIBITOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG PROTEIN BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032552850     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9492     Document Type: Article

References (26)

1. Ashcroft F. M., Rorsman P. Prog. Biophys. Mol. Biol. 54:1989;87-143.
2. Inagaki N., Gonoi T., Clement J. P. IV, Namba N., Inazawa J., Gonzalez G., Aguilar-Bryan L., Seino S., Bryan J. Science. 270:1995;1166-1170.
3. Ashcroft S. J. H., Ashcroft F. M. Cell. Signalling. 2:1990;197-214.
4. Gribble F. M., Tucker S. J., Ashcroft F. M. J. Physiol. 504:1997;35-45.
5. Proks P., Ashcroft F. M. Proc. Natl. Acad. Sci. USA. 94:1997;11716-11720.
6. Hilleman D. E., Mohiuddin S. M., Ahmed I. S., Dahl J. M. Drug. Intell. Clin. Pharm. 21:1987;38-40.
7. Jeandel C., Preiss M. A., Pierson H., Penin F., Cuny G., Bannwarth B., Netter P. Lancet. 8596:1988;1232-1233.
8. Garshot B. A., Bezier M., Cherrier J. F., Daubeze J. Lancet. 8605:1988;280.
9. Bertrand G., Gross R., Petit P., Loubatieres-Mariani M. M., Ribes G. Eur. J. Pharmacol. 214:1992;159-163.
10. Ishida-Takahashi A., Horie M., Tsuura Y., Ishida H., Ai T., Sasayama S. Br. J. Pharmacol. 117:1996;1749-1755.
11. Kakei M., Nakazaki M., Kamisaki T., Nagayama I., Fukamachi Y., Tanaka H. Br. J. Pharmacol. 109:1993;1226-1231.
12. Aguilar-Bryan L., Nichols C. G., Wechsler S. W., Clement J. P. IV, Boyd A. E. III, Gonzalez G., Herrera-Sosa H., Nguy K., Bryan J., Nelson D. A. Science. 268:1995;423-426.
13. Moriyoshi K., Richards L. J., Akazawa C., O'Leary D. D. M., Nakanishi S. Neuron. 16:1996;255-260.
14. Niwa H., Yamamura K., Miyazaki J. Gene. 108:1991;193-200.
15. Ogata N., Tatebayashi H. J. Neurosci. Method. 39:1991;175-183.
16. Mukai E., Ishida H., Kato S., Tsuura Y., Fujimoto S., Ishida-Tkahashi A., Horie M., Tsuda K., Seino Y. Am. J. Physiol. 274:1998;E38-E44.
17. Clement J. P. IV, Kunjilwar K., Gonzalez G., Schwanstecher M., Panten U., Aguilar-Bryan L., Bryan J. Neuron. 18:1997;827-838.
18. Inagaki N., Gonoi T., Seino S. FEBS Lett. 409:1997;232-236.
19. Shyng S. L., Nichols C. G. J. Gen. Physiol. 110:1997;655-664.
20. Tucker S. J., Gribble F. M., Zhao C., Trapp S., Ashcroft F. M. Nature. 387:1997;179-183.
21. Plant T. D., Henquin J. C. Br. J. Pharmacol. 101:1990;115-120.
22. Dunne M. J. Br. J. Pharmacol. 103:1991;1847-1850.
23. Horie M., Ishida-Takahashi A., Ai T., Nishimoto T., Tsuura Y., Ishida H., Seino Y., Sasayama S. Cadiovascular Res. 34:1997;69-72.
24. Tsuura Y., Ishida H., Okamoto Y., Tsuji K., Kurose T., Horie M., Imura H., Okada Y., Seino Y. Diabetes. 41:1992;861-865.
25. Tsuura Y., Ishida H., Okamoto Y., Kato S., Sakamoto K., Horie M., Ikeda H., Okada Y., Seino Y. Diabetes. 42:1993;1446-1453.
26. Östenson C.-G., Khan A., Abdel-Halim S. M., Guenifi A., Suzuki K., Goto Y., Efendic S. Diabetologia. 36:1993;3-8.